Predictive Value of A Proteomic Signature in Patients with Non-Small-Cell Lung Cancer Treated with Second-Line Erlotinib or Chemotherapy (prose): A Biomarker-Stratified, Randomised Phase 3 TrialVanesa Gregorc,Silvia Novello,Chiara Lazzari,Sandro Barni,Michele Aieta,Manlio Mencoboni,Francesco Grossi,Tommaso De Pas,Filippo de Marinis,Alessandra Bearz,Irene Floriani,Valter Torri,Alessandra Bulotta,Angela Cattaneo,Julia Grigorieva,Maxim Tsypin,Joanna Roder,Claudio Doglioni,Matteo Giaj Levra,Fausto Petrelli,Silvia Foti,Mariagrazia Vigano,Angela Bachi,Heinrich RoderLANCET ONCOLOGY（2014）引用 182|浏览37关键词Tumor Markers,Biomarker AnalysisAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
